CLASS II Device recall · Reported 29 Jan 2014 · FDA Enforcement Report

XiO RTP System The XiO RTP System is used to create recalled by Elekta

Elekta is recalling XiO RTP System The XiO RTP System is used to create treatment plans for any cancer, distributed in 7 states. The recall was initiated on 25 Nov 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesModel or Catalog No. MUJ; Software Version XiO Versions 4.80 and higher
Quantity recalled13

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0780-2014
FDA event ID
67078
Recalling firm
Elekta, Atlanta, GA
Classification
Class II
Status
Terminated
Recall initiated
25 Nov 2013
FDA classified
17 Jan 2014
Reported
29 Jan 2014
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

25 Nov 2013Recall initiated by company
17 Jan 2014Classified by FDA+53 days
29 Jan 2014Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

When the number of fractions is changed for a proton spot beam, the MU are recomputed and rounded if necessary, but the dose is not recalculated as it should be even after saving and re-opening the plan.

Product as listed by the FDA

XiO RTP System The XiO RTP System is used to create treatment plans for any cancer patient for whom external beam radiation therapy or brachytherapy has been prescribed. The system will calculate and display, both on-screen and in hard-copy, either two or three-dimensional radiation dose distributions within a patient for a given treatment plan set-up.

Where it was distributed

Worldwide Distribution - US Distribution including the states of IL, IN, LA, NJ, TX, WA and WI., and the countries of Belgium, Germany, Italy and Netherlands.

IllinoisIndianaLouisianaNew JerseyTexasWashingtonWisconsin

Questions about this recall

Is XiO RTP System The XiO RTP System is used to create treatment plans for any cancer recalled?

Yes. Elekta recalled XiO RTP System The XiO RTP System is used to create treatment plans for any cancer on 25 Nov 2013. The recall is Class II and its status is Terminated. Recall number Z-0780-2014.

Why was it recalled?

When the number of fractions is changed for a proton spot beam, the MU are recomputed and rounded if necessary, but the dose is not recalculated as it should be even after saving and re-opening the plan.

Which lots are affected?

Model or Catalog No. MUJ; Software Version XiO Versions 4.80 and higher

Where was it sold?

Worldwide Distribution - US Distribution including the states of IL, IN, LA, NJ, TX, WA and WI., and the countries of Belgium, Germany, Italy and Netherlands.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Elekta

All 122

Other Other Medical Devices recalls

All 13,778